Efficacy and safety analysis of chemotherapy combined with immunotherapy compared with standard chemotherapy for advanced biliary tract malignant tumors by Zhengfeng Zhang, Dazhen Wang, Liu Yang, Lu Zhao, Lei Yang, Jianji Zhang, Changjie Lou

Subjects: “…advanced biliary tract cancer…”
Get full text

A retrospective study of patient-tailored FOLFIRINOX as a first-line chemotherapy for patients with advanced biliary tract cancer by Ayhan Ulusakarya, Abdoulaye Karaboué, Oriana Ciacio, Gabriella Pittau, Mazen Haydar, Pamela Biondani, Yusuf Gumus, Amale Chebib, Wathek Almohamad, Pasquale F. Innominato

Subjects: Get full text

Safety and feasibility of toripalimab plus lenvatinib with or without radiotherapy in advanced BTC by Yunchao Wang, Nan Zhang, Jingnan Xue, Chengpei Zhu, Yanyu Wang, Longhao Zhang, Xu Yang, Hao Wang, Shanshan Wang, Jiashuo Chao, Xiaobo Yang, Haitao Zhao

Subjects: “…advanced biliary tract cancer…”
Get full text

Cost-effectiveness of pembrolizumab plus chemotherapy vs. chemotherapy as first-line treatment for advanced biliary tract cancer in China and the US by Xianmei Luo, Xianmei Luo, Tingting Cai, Tingting Cai, Jinyan Wu, Xingyu Li, Xingyu Li, Xiaofan Wang, Xiaofan Wang, Haiying Ma, Haiying Ma

Subjects: Get full text

Chemotherapy combined with regorafenib and immune checkpoint inhibitors as a first-line treatment for patients with advanced biliary tract cancer: a single arm phase II trial by Jianwei Liu, Shilei Bai, Yanfu Sun, Lei Hu, Ruiliang Ge, Feng Xue

Subjects: “…advanced biliary tract cancer…”
Get full text

FOLFIRI-bevacizumab as a second-line treatment for advanced biliary tract cancer after gemcitabine-based chemotherapy by Nicolas Roussot, Nicolas Roussot, Nicolas Roussot, Nicolas Roussot, Julie Vincent, Remi Palmier, Guillaume Constantin, Leila Bengrine, Jean-David Fumet, Jean-David Fumet, Jean-David Fumet, Jean-David Fumet, François Ghiringhelli, François Ghiringhelli, François Ghiringhelli, François Ghiringhelli, François Ghiringhelli

Subjects: Get full text

Efficacy and safety of lenvatinib combined with PD-1/PD-L1 inhibitors plus Gemox chemotherapy in advanced biliary tract cancer by Chengpei Zhu, Jingnan Xue, Yunchao Wang, Shanshan Wang, Nan Zhang, Yanyu Wang, Longhao Zhang, Xu Yang, Junyu Long, Xiaobo Yang, Xinting Sang, Haitao Zhao

Subjects: “…advanced biliary tract cancer…”
Get full text

The Efficacy and Safety of Apatinib Plus Camrelizumab in Patients With Previously Treated Advanced Biliary Tract Cancer: A Prospective Clinical Study by Dongxu Wang, Xu Yang, Junyu Long, Jianzhen Lin, Jinzhu Mao, Fucun Xie, Yunchao Wang, Yanyu Wang, Ziyu Xun, Yi Bai, Xiaobo Yang, Mei Guan, Jie Pan, Samuel Seery, Samuel Seery, Xinting Sang, Haitao Zhao

Subjects: Get full text

Cost-Effectiveness Analysis of Capecitabine Plus Oxaliplatin Versus Gemcitabine Plus Oxaliplatin as First-Line Therapy for Advanced Biliary Tract Cancers by Ruijia Chen, Yalan Zhang, Kongying Lin, Defu Huang, MaoJin You, Yanjin Lai, Jinye Wang, Yingying Hu, Na Li, Na Li

Subjects: Get full text